ArticleExperimental and therapeutic medicine2021

Cost-effectiveness analysis of different sequences of osimertinib administration for epidermal growth factor receptor-mutated non-small-cell lung cancer.

Wenqian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.